The AMA decides to join to 21st century and partners with Web 2.0 upstart Sermo. Pharmalot shares some concerns about the deal.
Related posts:
- Learning from Sermo
- Medgadget keeps the pressure on Sermo
- More Sermo and Pfizer
- The future of Sermo
- Sermo and Pfizer
- Another medblogger down
- The AMA and Sermo break up, and how it’s getting ugly
KevinMD.com on Facebook
{ 3 comments }
If the AMA is “in,” I’m out. I have asked Sermo to remove me from their list of online participants. I do not want my name associated at any time in any place with the AMA.
At Healtheva, we are bringing basic science researchers and clinical researchers into the equation.
Our focus is on both evaluating trends in the post market and also providing the tools to usher new innovative drugs and medical devices to the marketplace.
To accomplish this aim, we enable physicians, basic science researchers, and clinical researchers to create their own rich profile and social network. Members can then collaborate on papers, upload original images, podcasts, videos, and share annotations and insights on current medical literature, either with selected colleagues or with the broader Healtheva community.
Healtheva is currently in Beta and has members from leading academic teaching hospitals. Healtheva was started by graduates from MIT, Stanford, and Harvard Business School.
I encourage you to join the site and provide us with feedback.
Here is our site http://www.healtheva.com
Comments on this entry are closed.